Mastermind, which is a Notch signal component, is a nuclear protein and is thought to contribute to the transactivation of target genes. Previously we showed that XMam1, Xenopus Mastermind1, was essential in the transactivation of a Notch target gene, XESR-1, and was involved in primary neurogenesis. To examine the function of XMam1 during Xenopus early development in detail, XMam1-overexpressed embryos were analyzed. Overexpression of XMam1 ectopically caused the formation of a cell mass with pigmentation on the surface of embryos and expressed nrp-1. The nrp-1-positive cell mass was produced by XMam1 without expression of the Notch target gene, XESR-1, and not by the activation form of Notch, NICD. The ectopic expression of nrp-1 was not inhibited by coinjection of XMam1 with a molecule known to inhibit Notch signaling. The nrp-1 expression was also recognized in the animal cap injected with XMam1DN, which lacks the basic domain necessary for interacting with NICD and Su(H). These results show that XMam1 has the ability to induce the cell fate into the neurogenic lineage in a Notch-independent manner.
Introduction
During the development of multicellular organisms, cell-cell signal transduction is essential to generate various types of cells in addition to increasing the number of cells of a fertilized egg by cell division. Although many signal transduction systems are known, signal transduction by the direct contact of cells plays a particularly important role in juxtacrine signal transduction.
Notch signaling, whose existence was clarified by genetic analyses using Drosophila, is a signal transduction system which is widely conserved from vertebrates to invertebrates (Greenwald, 1994; Muskavitch, 1994; Artavanis-Tsakonas et al., 1995; Greenwald, 1998; Artavanis-Tsakonas et al., 1999; Mumm and Kopan, 2000) . Notch signaling is understood well in the neurogenesis of Drosophila and six loci (Delta, Notch, Enhancer of Split [E(spl)], neuralized, big brain, mastermind) have been identified by analyses of the mutant known as a neurogenic phenotype (Lehman et al., 1983; Jurgens et al., 1984; Nusslein-Volhard et al., 1984; Wieschaus et al., 1984) . These genes are called ''neurogenic genes '' (Campos-Ortega, 1993) . Many factors involved in Notch signaling have been identified and it is reported that Notch signaling contributes to cell fate decisions such as lateral inhibition, asymmetric division and induction (Simpson, 1994; Artavanis-Tsakonas et al., 1995; Spana and Doe, 1996; Greenwald, 1998) .
While the multifunction of Notch signaling has been revealed, the mechanism by which Notch signaling is activated has been clarified. Notch ligands, Delta and Serrate, interact with Notch receptor expressed on neighboring cells through an EGF-like repeat domain in the extracellular region, then the Notch intracellular domain (NICD) is cleaved by c-secretase, Presenilin (De Strooper et al., 1999; Struhl and Greenwald, 1999 into the nucleus and binds to CSL (CBF1, Suppressor of Hairless, LAG-1) family protein to transactivate target genes such as HES, Enhancer of Split [E(spl)] and ESR. It is expected that Mastermind forms a ternary complex with CSL and NICD to regulate the transactivation of Notch target genes (Fortini and Artavanis-Tsakonas, 1994; Christensen et al., 1996; Petcherski and Kimble, 2000; Wu et al., 2000 Wu et al., , 2004 Kitagawa et al., 2001) .
Mastermind has been identified as a neurogenic gene in Drosophila (Yedvobnick et al., 1988; Smoller et al., 1990; Newfeld et al., 1993) . In vertebrates, Mastermind has been identified in humans (Wu et al., 2000; Kitagawa et al., 2001 ) and the existence of three types of genes, hMam1, 2 and 3, has been revealed (Lin et al., 2002; Wu et al., 2002) . Recently, Maml1, a mouse homologue of Mastermind, has been isolated (Wu et al., 2004) . Three domains highly conserved in Mastermind protein are responsible for the mechanism of transactivation. The basic domain in N-terminus is involved in interacting with CSL family protein and NICD, whereas two acidic domains are essential for activating the transcription of target genes (Petcherski and Kimble, 2000; Wu et al., 2000 Wu et al., , 2002 Kitagawa et al., 2001; Fryer et al., 2002; Lin et al., 2002; Nam et al., 2003) .
Mastermind is believed to contribute to the transactivation of Notch target genes and to repress excess formation of the nervous system in Drosophila. If this function is conserved in other animals, Mastermind should function in neurogenesis in vertebrates, including Xenopus. Previously, we identified Xenopus Mastermind1, XMam1, and analyzed the expression profile and function of XMam1 in early development. We showed that XMam1 repressed a primary neuron marker, N-tubulin expression, and was essential for transactivation of the Notch target gene, XESR-1 (Katada and Kinoshita, 2003) . However, during our experiments, we noticed that the up-regulation of XESR-1 was induced by NICD, but not by XMam1, although both could repress primary neurogenesis. These results suggest that XMam1 should have another function distinguished from canonical Notch signaling through XESR-1 transactivation.
Here, we analyzed XMam1-overexpressed embryos by comparing with NICD-injected embryos to clarify the other function of XMam1. Functional analyses using microinjection of the wild-type and truncated forms of XMam1 showed that XMam1 could induce ectopically generated nrp-1-positive cells in a Notch-independent manner. These results suggest that XMam1 is responsible for cell fate decisions in a Notch-dependent and -independent manner in embryo neurogenesis.
Results

Overexpression of XMam1 causes the formation of hyperpigmented cell mass
To analyze the role of XMam1 in detail, we first examined the function of full-length XMam1 (Fig. 1) , basing on morphological changes in XMam1-overexpressed embryos. Two nanograms of XMam1 or NICD mRNA was injected into one dorsoanimal blastomere at the 8-cell stage and the phenotype was observed at various stages. GFP mRNA was co-injected as a tracer to confirm the injected side. Both XMam1-injected and NICD-injected embryos showed normal development until early neurula stage; however, XMam1-overexpressed embryos showed swelling of the neural plate in the injected domain at st. 13-15. The rate of embryos showing this phenotype was about 20% of total embryos.
The typical phenotype in the XMam1-injected embryos was first recognized at st. 20 and became clear at st. 30 (Fig. 2) . The formation of a hyperpigmented cell mass and incomplete development of the eye vesicle were observed in the XMam1-injected embryos (89%, n = 47) ( Fig. 2E-G) . Incomplete extension of the body axis was also seen in about 10% of total embryos. In contrast, protrusion of the head region was seen in NICD-injected embryos as described previously (75%, n = 16) ( Fig. 2I -K) (Coffman et al., 1993) . To test whether these phenotypes have regional specificity, 2 ng of XMam1 or NICD mRNA was injected into one ventroanimal blastomere of an 8-cell stage embryo and the phenotype was observed at st. 30 (Fig. 2D , H, and L). Overexpression of XMam1 caused formation of the cell mass with pigment, similar to injection on the dorsal side (100%, n = 43) (Fig. 2H) . However, NICD-injected embryos showed slight hyperplasia of non-pigmented tissue on the injected side, different from the case of dorsal injection (100%, n = 23) (Fig. 2L) .
Histological examination showed that overexpression of XMam1 caused the enlargement of ectodermal tissue, in which pigment cells are produced (Fig. 3) . The pigmented ectodermal cell mass was not detected in the NICD-overexpressed embryo. Fig. 1 . XMam1 constructs. The scheme of XMam1 constructs used in this experiment. Blue, orange and red boxes represent basic domain, NLS (nuclear localization signal) and acidic domain, respectively. Numerals show the position of amino acid residues.
XMam1 induces neural-specific markers and nrp-1 -positive cells in vivo
To test the genes activated by XMam1 in animal caps, RT-PCR was performed using various tissue-specific markers. XMam1 mRNAs were injected into both blastomeres of a 2-cell stage embryo, and animal caps were dissected at st. 8. After 1-day incubation, the animal caps were harvested at st. 25 for RT-PCR analyses. As tissue-specific markers, SoxD, nrp-1 and NCAM for neural markers, Xslug for neural crest, XESR-1 for the target of Notch signaling, XK81A1 for epidermal keratin, XmyoD for muscle and Xsox17a for endoderm were used. As shown in Fig. 4A , XMam1 specifically induced the expression of neural marker genes although XMam1-induced NCAM was lower than that of Chordin. XMam1 also induced Xslug expression, but did not transactivate XESR-1 expression. As to XK81A1 expression, decreased expression was observed in chordin-overexpressed caps, but no change was observed in XMam1-overexpressed caps. XMam1 did not induce XmyoD or Xsox17a expression.
To examine whether XMam1 induces a neural marker in vivo, embryos were injected with 2 ng of XMam1 or NICD into one ventroanimal blastomere at the 8-cell stage and nrp-1 expression was analyzed at st. 30 by wholemount in situ hybridization (Fig. 4B , D, and F). The ectopic expression of nrp-1 was observed in almost all the XMam1-injected embryos (98%, n = 57). About 32% (n = 37) of the embryos injected with NICD showed the ectopic expression of nrp-1, but the gene expression of nrp-1 was quite faint. In contrast to the ectopic expression of nrp-1, XMam1 did not induce the gene expression of XESR-1, whereas NICD caused the ectopic expression of XESR-1 (Fig. 4C , E, and G). These results suggest that XMam1 has the ability to produce nrp-1-positive cells without the transactivation of XESR-1.
Ectopic nrp-1 expression induced by XMam1 occurs without Notch signaling
As shown above, XMam1 produces nrp-1-positive cells without the transactivation of XESR-1, a target gene in Notch signaling. To examine whether XMam1 induces nrp-1 expression in a Notch-independent manner, we used four types of the dominant-negative forms for Notch signaling, X-Delta-1 Stu , X-Serrate-1
Eco , NDICD and XSu(H)1 DBM . X-Delta-1 Stu and X-Serrate-1 Eco are dominant-negative forms lacking the intracellular domain of X-Delta-1 and X-Serrate-1, respectively. It is reported that the overexpression of these genes results in overproduction of the primary neuron (Chitnis et al., 1995; Kiyota et al., 2001) . NDICD is also the dominant-negative form because it lacks the intracellular domain of X-Notch-1 and interacts with Notch ligand, but cannot release the Notch intracellular domain into cytoplasm (Lyman and Young, 1993; Rebay et al., 1993; Greenwald, 1994; Kiyota and Kinoshita, 2002 ). X-Su(H)1 DBM lacks the ability to bind to DNA and is considered to inhibit normal signal transduction by trapping endogenous NICD (Wettstein et al., 1997) . These samples were co-injected with XMam1 into one ventroanimal blastomere at the 8-cell stage and nrp-1 expression was analyzed at st. 25 by whole-mount in situ hybridization (Fig. 5A-J) . Regardless of inhibiting Notch signaling, the ectopic expression of nrp-1 was observed in all cases. As shown previously (Katada and Kinoshita, 2003) , XMam1DC is the dominant-negative form which has a basic domain interacting with NICD/Su(H), but lacks the activation domain (Fig. 1) . Even in an embryo co-injected with XMam1 and XMam1DC, nrp-1 was induced ectopically on the injection side ( Fig. 5K and L) .
In order to examine whether XMam1 can induce nrp-1 expression without Notch signaling in vitro, samples were injected into both blastomeres in the animal pole at the 2-cell stage and animal cap assays were performed using RT-PCR with nrp-1 and XESR-1 primers (Fig. 6) . As is well known, NICD activates XESR-1 transcription, which was diminished by the co-injection of X-Su(H)1 DBM (Fig. 6 , lanes 5 and 9). Although a weak expression of nrp-1 was ectopically induced by NICD in vitro, the expression was completely suppressed by co-injection with X-Su(H)1 DBM . In contrast, XMam1 induced the definite expression of nrp-1, which was maintained even in caps co-injected with X-Su(H)1 DBM (Fig. 6, lanes 4 and 8) . These results suggest that XMam1 can induce nrp-1 expression without Notch signaling.
XMam1 induces nrp-1 expression in a Notchindependent manner
To confirm that XMam1 can induce nrp-1 expression in a Notch-independent manner, we prepared another construct, and XMam1 (D), X-Serrate-1 Eco (E), X-Serrate-1 Eco and XMam1 (F), NDICD (G), NDICD and XMam1 (H), X-Su(H)1 DBM (I), X-Su(H)1 DBM and XMam1 (J), XMam1DC (K), XMam1DC and XMam1 (L). Ectopic nrp-1 expression was detected in the embryo injected with XMam1, regardless of the inhibition of Notch signaling. (Fig. 1) . The study on human Mastermind has shown that the basic domain in the N-terminus of Mastermind protein is involved in binding to CSL and NICD (Petcherski and Kimble, 2000; Wu et al., 2000 Wu et al., , 2002 Kitagawa et al., 2001; Fryer et al., 2002; Lin et al., 2002; Nam et al., 2003) . Therefore, XMam1DN, which lacks the basic domain, is expected to lose a function in Notch signaling because of the failure to form a complex with CSL and NICD. Initially, to examine the ability of XMam1DN, we tested whether XMam1DN loses the ability to rescue the decrease of XESR-1 transcription caused by XMam1DC. Samples were injected into one blastomere of 2-cell stage embryos and XESR-1 expression was detected at st. 14 by whole-mount in situ hybridization. As shown in Fig. 7C and D, XMam1DC suppressed XESR-1 expression on the injection side, which was rescued by co-injecting with XMam1. However, XMam1DN could not rescue the XMam1DC-induced suppression of XESR-1 (Fig. 7E) , indicating that XMam1DN has lost the ability to interact with CSL and NICD. The same result was quantitatively obtained by RT-PCR (Fig. 7A) . These results indicate that XMam1DN has lost the ability to interact with CSL and NICD.
XMam1DN
Next, we examined whether the ectopic expression of nrp-1 is induced by the truncated form, XMam1DN. Samples were injected into both blastomeres of 2-cell stage embryos and animal caps were isolated at st. 8. Gene expressions of nrp-1, chordin and XMam1 were examined by RT-PCR at st. 25. As well as wild-type XMam1, the truncated form of XMam1, XMam1DN, also induced the ectopic expression of nrp-1 (Fig. 8, lanes 5 and 6) . These results suggest that the XMam1-induced ectopic gene expression of nrp-1 occurs in a Notch-independent manner. In this experiment, GFPand chordin-injected caps were used as negative and positive controls, respectively. As is well known, chordin has the ability to induce the gene expression of neural markers (Sasai et al., 1994) ; chordin induced the ectopic expression of nrp-1 (Fig. 8, lane 4) . In order to test whether XMam1-induced nrp-1 expression is mediated by chordin, the gene expression of chordin was examined in the XMam1-or XMam1DN-injected animal cap. As shown in Fig. 8 , lanes 5 and 6, both XMam1 and XMam1DN were not able to induce the ectopic gene expression of chordin. These results indicate that XMam1-induced nrp-1 expression is not mediated by the gene expression of chordin.
Discussion
XMam1 functions as a neural inducer in a Notchindependent manner
It is expected that the overexpression of XMam1 causes the same morphological changes as NICD overexpression, since both Notch and Mastermind positively regulate Notch signaling in Drosophila. As has been shown previ- To test the inductive effect of XMam1 in vitro, 1 ng of samples were injected into animal poles of both blastomeres at the 2-cell stage. The animal caps isolated at st. 8 were cultured to st. 25 and gene expression was analyzed by RT-PCR using nrp-1 and XESR-1 primers. Both XMam1 and NICD induced nrp-1 in animal caps, although NICD induced weak expression of nrp-1. The nrp-1 induction by XMam1 was not inhibited by co-injection with X-Su(H)1 DBM , whereas nrp-1 induction by NICD was completely suppressed by co-injection with X-Su(H)1 DBM . Gene expression of XESR-1 was induced by NICD but not by XMam1. GFP was used as a tracer for microinjection. Ectopic gene expression was not induced by injecting with GFP, XSu(H)1 nor X-Su(H)1 DBM . Histone H4 was used as an internal control. WE, whole embryo. Fig. 7 . XMam1DN is not involved in Notch signaling. To confirm that XMam1DN is not involved in Notch signaling, we examined whether XMam1DN could rescue the down-regulation of XESR-1 transcription caused by XMam1DC. Samples were injected into one blastomere of 2-cell stage embryos and XESR-1 expression was analyzed at st. 14 by RT-PCR (A) or by whole-mount in situ hybridization (B-E). XESR-1 expression was suppressed by injecting with XMam1DC (A-C). The suppression of XESR-1 expression by XMam1DC could be rescued by co-injecting with XMam1 (A and D), but not with XMam1DN (A and E). Black rectangles in B-E represent the injected side. The injected region was colored blue by b-galactosidase staining.
ously (Coffman et al., 1993) , disorganization of the eye vesicle and brain enlargement occurred in NICD-injected embryos. However, XMam1-overexpressed embryos generated a cell mass with pigmentation on the body surface, which is different from the phenotype generated in NICD-injected embryos (Fig. 2) . The ectopic expression of nrp-1 was remarkably observed in XMam1-injected embryos regardless of the injected position, whereas only a weak expression of nrp-1 was observed in NICD-injected embryos (Fig. 4) . These results suggest that phenomena caused by XMam1 occur in a Notch-independent manner.
Co-injection of XMam1 with a molecule that negatively regulates Notch signaling resulted in the ectopic expression of nrp-1 (Fig. 6 ). More direct evidence is that XMam1DN as a dominant-negative form of XMam1 was able to induce nrp-1 expression (Fig. 8) . These results indicate the function of XMam1 independent of Notch signaling. This speculation is consistent with the previous report that components of Notch signaling have a function independent of Notch signaling (Martinez Arias et al., 2002) . For example, in myogenic cells, C2C12, differentiation to the myotube is repressed by the truncated form of NICD. The truncated form of NICD does not activate the CBF-1 dependent promoter, whereas truncated NICD can inhibit differentiation even in the presence of the dominant-negative form of CSL (Shawber et al., 1996; Nofziger et al., 1999) .
The mechanism by which XMam1 induces the expression of the neural gene
One possible mechanism by which XMam1 induces neurogenesis is suppression of the function of a neural inhibitor such as BMP. Since Mastermind protein works in the nucleus, it is impossible to inhibit BMP signal in an extracellular region-like Chordin or Noggin. In BMP signaling, Smad1 and 5 function as pathway-restricted Smads, whereas Smad6 and 7 function as inhibitory Smads (Heldin et al., 1997) . XMam1 may interact with these molecules in the nucleus, resulting in the inhibition of BMP signaling.
In neurogenesis induced by Chordin, XK81A1 expression in animal caps is repressed since Chordin induces neural tissue by inhibiting BMP signaling which promotes differentiation of the ectodermal cell into the epidermis (Hemmati-Brivanlou and Melton, 1997; Munoz-Sanjuan and Hemmati-Brivanlou, 2002) . In this study, however, XMam1 induced neural-specific markers, but showed no effect on XK81A1 expression (Fig. 4A) . Therefore, XMam1 probably functions in neurogenesis without inhibiting BMP signaling. This idea is consistent with the result that XMam1-induced nrp-1 expression occurs without gene expression of chordin (Fig. 8) .
It has been shown that Mastermind activates Notch signaling through binding to NICD and CBF1, mouse homologues of Su(H) (Petcherski and Kimble, 2000) . Also, in Xenopus embryos, XMam1 serves as a co-activator for the gene expression of XESR-1, which in turn inhibits primary neurogenesis (Katada and Kinoshita, 2003) . Therefore, there is a possibility that excess XMam1 inhibits Notch signaling by trapping the NICD/XSu(H) complex. Actually, the truncated form XMam1DC is thought to inhibit Notch signaling by competitive binding to the NICD/XSu(H) complex. However, the deficient phenotype induced by XMam1DC can be rescued by co-injection with full-length XMam1 (Katada and Kinoshita, 2003;  Fig. 7 ). In addition, the inhibitory form of Notch-related molecules could not induce the ectopic expression of nrp-1 (Fig. 5) , showing that the ectopic expression of nrp-1 is not induced by inhibiting Notch signaling.
Mastermind protein has two conserved activation domains necessary for Notch signaling. It has been shown that the first activation domain recruits histone acetyl transferase, CBP/p300, whereas the second activation domain is required for the phosphorylation of CBP/p300 proteins (Fryer et al., 2002) . Therefore, one possibility is that the overexpression of Mastermind may promote the widespread phosphorylation of CBP/p300 proteins. CBP/ p300 phosphorylation has been shown to alter its activity and affects its interaction with other transcription factors (Ait-Si-Ali et al., 1998) . It has been shown that mammal Mastermind-like protein interacts with co-transcriptional regulator MEF2, and promotes myogenic differentiation without Notch signaling (Shen et al., 2006) . XMam1 may cause neural induction by interacting with nuclear factors.
Experimental procedures
Embryos
Xenopus eggs obtained by injecting with 200 U of human chorionic gonadotropin, Gestron (Denka Seiyaku, Japan) were fertilized artificially. Embryos were dejellied with 1% sodium thioglycolate and cultured in 0.1· Fig. 8 . XMam1 induces nrp-1 expression in a Notch-independent manner. To test whether XMam1 is able to induce nrp-1 expression without interaction with Notch signaling molecules, XMam1DN was injected into both blastomeres of 2-cell stage embryos. Animal caps were dissected from the injected embryo and gene expression was analyzed at st. 25 by RT-PCR. XMam1DN induced nrp-1 expression as well as XMam1 without the ectopic gene expression of chordin. Chordin also induced nrp-1 expression without the gene expression of XMam1. GFP was used as the tracer for microinjection. Histone H4 was used as an internal control. WE, whole embryo; ND, no data.
MBS (Modified Barth's Solution). The developmental stages of embryos were determined according to normal table of Xenopus laevis (Nieuwkoop and Faber, 1967) .
Capped mRNA synthesis and microinjection
Full length of XMam1 and XMam1DC were used as described previously (Katada and Kinoshita, 2003) . For XMam1DN construct, the product obtained by PCR cloning with following primer sets was subcloned into BamHI/XhoI sites in pCS2+ (Fig. 1). XMam1DN forward, 5 0 -GGGGGATCCATGAGGCAGCAGCTCAGCCGCAGA-3 0 ; XMam1DN reverse, 5 0 -GGGCTCGAGTCAATGATTGCCAAGCAACTC-3 0 . For full length of X-Su(H)1 construct, the product obtained by PCR cloning was subcloned into pCS2+. X-Serrate-1
Eco (Kiyota et al., 2001 ) and NDICD (Kiyota and Kinoshita, 2002) were prepared as described previously. X-Delta-1
Stu (Chitnis et al., 1995) , NICD (Notch intracellular domain) (Chitnis and Kintner, 1996) and X-Su(H)1 DBM (Wettstein et al., 1997) were provided by Dr. C. Kintner. Chordin was provided by Dr. Y. Sasai (Sasai et al., 1994) . All capped mRNAs were synthesized with SP6 RNA polymerase after linearizing by NotI. GFP RNA was produced from pCS2mtUGP (kind gift from Dr. M. Klymkowsky). b-Galactosidase RNA was produced from pCMV-SPORT b-gal (Stratagene). Fertilization, culture and microinjection were performed as described previously (Moon and Christian, 1989; Asashima et al., 1990 ).
Histological analysis
For histological analysis, injected embryos were fixed in MEMFA for overnight and washed three times with PBS and replaced with 15% gelatin/15% sucrose in PBS for overnight. Thereafter, embryos were embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek, USA) for 1 h and frozen. The section with 14 lm thickness was dried for 3 h and washed with PBS for 5 min three times. These sections were treated with Hoechst 33342 (5 lg/ml in PBS) for 10 min and washed with PBS three times and mounted in 10% glycerol in PBS.
RT-PCR
Extraction of total RNAs was performed using ISOGEN (Wako, Japan) according to a manufacturer's protocol. Reverse transcriptional reaction was performed by Reverscript I (Wako, Japan) using 0.1 lg of total RNA and oligo(dT) primer. Annealing temperature was 55°C in all cases. Sequence of primer sets and cycle number are follows: SoxD forward, 
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed according to the improved method of Shain and Zuber (1996) . The antisense probe for nrp-1 (A kind gift from Dr. P. Good) was generated by linearizing with NotI and transcribing with T3 RNA polymerase in presence of digoxygenin-UTP (Rö che Diagnostics) (Richter et al., 1988 (Richter et al., , 1990 . XESR-1 probe was prepared as described previously (Katada and Kinoshita, 2003) . Hybridized probes were visualized according to the Rö che Diagnostics DIG protocol, with the minor alternation that 0.45 ll NBT (75 mg/ml in dimethyl formamide) and 3.5 ll BCIP (Rö che Diagnostics) were added to 1 ml AP buffer (100 mM Tris-HCl (pH 9.5), 100 mM NaCl, 50 mM MgSO 4 , 0.1% Tween 20 and 2.5 mM levamisole).
